Industry News

  • FDA Approves ViiV Healthcare's Dovato for Adolescent Use

    ViiV Healthcare, majority owned by GSK, received FDA approval for Dovato (dolutegravir/lamivudine) to treat HIV-1 in adolescents aged 12 and older, weighing at least 25 kg. This marks the first oral, two-drug, single-tablet regimen for this age group. Approval is supported by the DANCE study and adult trials.

    Read More
  • PPG Unveils New Zinc Epoxy Powder Primer

    PPG's new Primeron Optimal zinc epoxy powder primer offers enhanced transfer efficiency, lower density, and superior corrosion resistance while reducing costs and VOC emissions, ensuring strong adhesion and sustainability.

    Read More

   Page 1 of 122 Next